Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy

Susan L. Greenspan, Subashan Perera, Robert R. Recker, Julie M. Wagner, Parmatma Greeley, Bryon R. Gomberg, Pamela Seaman, Michael Kleerekoper

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: In addition to bone mineral density (BMD), trabecular microstructure contributes to skeletal strength. Our goal was to examine changes in trabecular microstructure in women on therapy. Materials and methods: We followed 10 postmenopausal women receiving a bisphosphonate, risedronate (35 mg once weekly), over 12 months and examined trabecular microarchitecture with high resolution wrist MR images (hr-MRI). MRI parameters included bone volume/total volume (BV/TV), surface density (representing plates), curve density (representing rods), surface-to-curve ratio and erosion index (depicting deterioration). We assessed BMD of the spine, hip and radius and markers of bone turnover. Results: Women had been receiving bisphosphonate therapy for 43±9 months (mean±SD) prior to the first MRI. Indices of hr-MRI demonstrated improvement in surface-to-curve ratio (13.0%) and a decrease in erosion index (12.1%) consistent with less deterioration (both p

Original languageEnglish
Pages (from-to)1006-1010
Number of pages5
JournalBone
Volume46
Issue number4
DOIs
StatePublished - Apr 2010

Fingerprint

Diphosphonates
Wrist
Bone Density
Bone Remodeling
Hip
Spine
Therapeutics
Bone and Bones

All Science Journal Classification (ASJC) codes

  • Physiology
  • Endocrinology, Diabetes and Metabolism
  • Histology

Cite this

Greenspan, S. L., Perera, S., Recker, R. R., Wagner, J. M., Greeley, P., Gomberg, B. R., ... Kleerekoper, M. (2010). Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy. Bone, 46(4), 1006-1010. https://doi.org/10.1016/j.bone.2009.12.025

Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy. / Greenspan, Susan L.; Perera, Subashan; Recker, Robert R.; Wagner, Julie M.; Greeley, Parmatma; Gomberg, Bryon R.; Seaman, Pamela; Kleerekoper, Michael.

In: Bone, Vol. 46, No. 4, 04.2010, p. 1006-1010.

Research output: Contribution to journalArticle

Greenspan, SL, Perera, S, Recker, RR, Wagner, JM, Greeley, P, Gomberg, BR, Seaman, P & Kleerekoper, M 2010, 'Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy', Bone, vol. 46, no. 4, pp. 1006-1010. https://doi.org/10.1016/j.bone.2009.12.025
Greenspan, Susan L. ; Perera, Subashan ; Recker, Robert R. ; Wagner, Julie M. ; Greeley, Parmatma ; Gomberg, Bryon R. ; Seaman, Pamela ; Kleerekoper, Michael. / Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy. In: Bone. 2010 ; Vol. 46, No. 4. pp. 1006-1010.
@article{55c03370283c48c19c925b080c1c3bb0,
title = "Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy",
abstract = "Purpose: In addition to bone mineral density (BMD), trabecular microstructure contributes to skeletal strength. Our goal was to examine changes in trabecular microstructure in women on therapy. Materials and methods: We followed 10 postmenopausal women receiving a bisphosphonate, risedronate (35 mg once weekly), over 12 months and examined trabecular microarchitecture with high resolution wrist MR images (hr-MRI). MRI parameters included bone volume/total volume (BV/TV), surface density (representing plates), curve density (representing rods), surface-to-curve ratio and erosion index (depicting deterioration). We assessed BMD of the spine, hip and radius and markers of bone turnover. Results: Women had been receiving bisphosphonate therapy for 43±9 months (mean±SD) prior to the first MRI. Indices of hr-MRI demonstrated improvement in surface-to-curve ratio (13.0{\%}) and a decrease in erosion index (12.1{\%}) consistent with less deterioration (both p",
author = "Greenspan, {Susan L.} and Subashan Perera and Recker, {Robert R.} and Wagner, {Julie M.} and Parmatma Greeley and Gomberg, {Bryon R.} and Pamela Seaman and Michael Kleerekoper",
year = "2010",
month = "4",
doi = "10.1016/j.bone.2009.12.025",
language = "English",
volume = "46",
pages = "1006--1010",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy

AU - Greenspan, Susan L.

AU - Perera, Subashan

AU - Recker, Robert R.

AU - Wagner, Julie M.

AU - Greeley, Parmatma

AU - Gomberg, Bryon R.

AU - Seaman, Pamela

AU - Kleerekoper, Michael

PY - 2010/4

Y1 - 2010/4

N2 - Purpose: In addition to bone mineral density (BMD), trabecular microstructure contributes to skeletal strength. Our goal was to examine changes in trabecular microstructure in women on therapy. Materials and methods: We followed 10 postmenopausal women receiving a bisphosphonate, risedronate (35 mg once weekly), over 12 months and examined trabecular microarchitecture with high resolution wrist MR images (hr-MRI). MRI parameters included bone volume/total volume (BV/TV), surface density (representing plates), curve density (representing rods), surface-to-curve ratio and erosion index (depicting deterioration). We assessed BMD of the spine, hip and radius and markers of bone turnover. Results: Women had been receiving bisphosphonate therapy for 43±9 months (mean±SD) prior to the first MRI. Indices of hr-MRI demonstrated improvement in surface-to-curve ratio (13.0%) and a decrease in erosion index (12.1%) consistent with less deterioration (both p

AB - Purpose: In addition to bone mineral density (BMD), trabecular microstructure contributes to skeletal strength. Our goal was to examine changes in trabecular microstructure in women on therapy. Materials and methods: We followed 10 postmenopausal women receiving a bisphosphonate, risedronate (35 mg once weekly), over 12 months and examined trabecular microarchitecture with high resolution wrist MR images (hr-MRI). MRI parameters included bone volume/total volume (BV/TV), surface density (representing plates), curve density (representing rods), surface-to-curve ratio and erosion index (depicting deterioration). We assessed BMD of the spine, hip and radius and markers of bone turnover. Results: Women had been receiving bisphosphonate therapy for 43±9 months (mean±SD) prior to the first MRI. Indices of hr-MRI demonstrated improvement in surface-to-curve ratio (13.0%) and a decrease in erosion index (12.1%) consistent with less deterioration (both p

UR - http://www.scopus.com/inward/record.url?scp=77950532416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950532416&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2009.12.025

DO - 10.1016/j.bone.2009.12.025

M3 - Article

C2 - 20051275

AN - SCOPUS:77950532416

VL - 46

SP - 1006

EP - 1010

JO - Bone

JF - Bone

SN - 8756-3282

IS - 4

ER -